Surgery Partners, Inc. (SGRY)
NASDAQ: SGRY · Real-Time Price · USD
26.95
+0.37 (1.39%)
At close: Nov 13, 2026, 4:00 PM EST
26.89
-0.06 (-0.22%)
After-hours: Nov 13, 2026, 7:30 PM EST
Surgery Partners Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, Surgery Partners stock has a consensus rating of "Hold" and an average price target of $24.4. The average 1-year stock price forecast is 9.46% lower than the current stock price, while the lowest is $23.5 (-12.80%) and the highest is $25 (-7.24%).
Price Target: $24.4 (-9.46%)
Analyst Consensus: Hold
Price Target
ChartAnalyst Ratings
The average analyst rating for Surgery Partners stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 8 | 8 | 8 | 1 | 0 |
| Buy | 1 | 1 | 1 | 1 | 0 | 0 |
| Hold | 3 | 3 | 3 | 3 | 6 | 6 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 12 | 12 | 7 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Hold Maintains $24 → $25 | Hold | Maintains | $24 → $25 | -7.24% | Nov 11, 2026 |
| Mizuho Securities | Mizuho Securities | Hold Downgrades $19 → $25 | Hold | Downgrades | $19 → $25 | -7.24% | Nov 11, 2026 |
| RBC Capital | RBC Capital | Hold Maintains $24 → $25 | Hold | Maintains | $24 → $25 | -7.24% | Nov 10, 2026 |
| UBS | UBS | Hold Downgrades $21 → $24 | Hold | Downgrades | $21 → $24 | -12.80% | Oct 27, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Downgrades $18 → $24 | Hold | Downgrades | $18 → $24 | -12.80% | Oct 26, 2026 |
Financial Forecast
Revenue This Year
3.20B
from 3.31B
Decreased by -3.42%
Revenue Next Year
2.92B
from 3.20B
Decreased by -8.63%
EPS This Year
0.37
from 0.47
Decreased by -21.28%
EPS Next Year
0.18
from 0.37
Decreased by -50.77%
EPS and Forward PE are based on non-GAAP adjusted numbers.